We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
ClinicalTrials.gov Menu

A Phase 1 Study to Evaluate FN-1501 Monotherapy in Patients With Advanced Solid Tumors and R/R AML

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03690154
Recruitment Status : Terminated (Despite demonstrated safety and tolerability the trial was terminated early due to program re-prioritization in light of the competitive landscape.)
First Posted : October 1, 2018
Last Update Posted : July 13, 2022
Information provided by (Responsible Party):
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : February 11, 2022
Actual Study Completion Date : February 11, 2022